Skip to main content
. 2011 Feb 18;32(6):1617–1624. doi: 10.1007/s00296-011-1807-0

Fig. 1.

Fig. 1

Kaplan–Meier analysis for continuation rates of etanercept between the pre-IFX and non-IFX groups. IFX = infliximab. P < 0.001 for pre-IFX vs. non-IFX (log-rank test)